Chondroitin sulphate inhibits NF-κB activity induced by interaction of pathogenic and damage associated molecules

This publication has 38 references indexed in Scilit:

• Activation and regulation of the inflammasomes
  Nature Reviews Immunology, 2013
• Contact Sensitizers Induce Skin Inflammation via ROS Production and Hyaluronic Acid Degradation
  PLOS ONE, 2012
• Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
  Annals of the Rheumatic Diseases, 2011
• Hyaluronan as an Immune Regulator in Human Diseases
  Physiological Reviews, 2011
• Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT
  Annals of the Rheumatic Diseases, 2010
• The Inflammasomes
  Cell, 2010
• The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages
  PLOS ONE, 2010
• Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
  Diabetes, 2007
• High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice
  Journal of Gastroenterology, 2004
• Structure, Regulation and Function of NF-kappaB
  Annual Review of Cell Biology, 1994